Skip to content

Negative Venous Line Pressure in a Miniaturised Cardiopulmonary Bypass Circuit (CPB)

Negative Venous Line Pressure in a Miniaturised Cardiopulmonary Bypass Circuit - the Influence of a Fenestrated Venous Cannula and Its Effect on Pump Flow

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03717649
Enrollment
48
Registered
2018-10-24
Start date
2016-01-12
Completion date
2016-10-31
Last updated
2018-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Surgery

Brief summary

Study to measure the ability of a 'fenestrated' venous line cannula to reduce the negative line pressure seen with kinetic-assist active venous drainage (KAVD) in a standard miniaturised cardiopulmonary bypass circuit and thereby increase the flow characteristics of the bypass pump.

Detailed description

To investigate whether a new venous drainage pipe (cannula) which has three sets of drainage holes (three-stage) compared with the standard two-stage cannula, or a three-stage which also has additional windows (fenestrations), can improve the drainage of blood into the circuit, reducing the negative pressure produced and increase the blood flow delivered to the patient. Patients who consent to participate will be randomly assigned to one of three types of venous cannula: 1. Standard venous cannulation with a two-stage venous cannula 2. The three-stage cannula (91437C, Medtronic) 3. The fenestrated three-stage cannula (MC2X, Medtronic)

Interventions

DEVICEConventional 2-stage venous cannula

venous cannula

DEVICEConventional 3-stage venous cannula

venous cannula

DEVICEFenestrated 3-stage venous cannula

venous cannula

Sponsors

University Hospital Plymouth NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

A single centre, prospective, randomised, double-blind trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients over the age of 18 years of age scheduled to undergo isolated Coronary Artery Bypass Grafting (CABG) or isolated Aortic Valve Replacement (AVR), who are able and willing to consent. * Consultant surgeon willing to operate using either Mini-CPB for CABG or AVR surgery.

Exclusion criteria

* Re-operation and emergency surgery * Patients refusing or unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Average blood flowduration of surgeryAverage blood flow measured in litres per minute per body surface area meter (squared).

Secondary

MeasureTime frameDescription
Negative pressure readingsduration of surgeryThe duration and depth of negative pressure readings from the venous line during cardiopulmonary bypass (CPB) are made in negative pressure readings in mmHg.
Number of microbubblesduration of surgeryMeasured as total count (n).
Size of microbubblesduration of surgeryMeasured as total volume (ml).
Haemolysisduration of surgeryDifferences in the rate of haemolysis associated with the cannula is measured by the relative increase in plasma alanine aminotransferase (ALT) concentration U/l, as a percentage change from baseline at each of 3 later timepoints.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026